addit
surfac
glycoprotein
gp
ebola
viru
ebov
direct
product
larg
quantiti
truncat
glycoprotein
isoform
sgp
secret
extracellular
space
gener
secret
antigen
studi
sever
virus
suggest
mechan
host
immun
evas
absorpt
antibodi
interfer
antibodymedi
clearanc
howev
role
conclus
determin
ebola
viru
sgp
studi
immun
mice
dna
construct
express
gp
andor
sgp
demonstr
sgp
effici
compet
antigp
antibodi
mice
immun
sgp
term
phenomenon
antigen
subvers
propos
model
wherebi
sgp
redirect
host
antibodi
respons
focu
epitop
share
membranebound
gp
therebi
allow
absorb
antigp
antibodi
unexpectedli
found
sgp
also
subvert
previous
immun
host
antigp
respons
result
strong
crossreact
sgp
find
particularli
relev
ebov
vaccinolog
sinc
underscor
import
elicit
robust
immun
suffici
rapidli
clear
infect
antigen
subvers
occur
antigen
subvers
repres
novel
viru
escap
strategi
like
help
ebov
evad
host
immun
may
repres
import
obstacl
ebov
vaccin
design
ebola
viru
ebov
envelop
singlestrand
negativesens
rna
viru
order
mononegaviral
along
marburg
viru
marv
form
filoviru
famili
ebov
etiolog
agent
ebola
hemorrhag
fever
ehf
highli
lethal
hemorrhag
fever
mortal
sinc
discoveri
ebov
caus
sporad
outbreak
subsaharan
africa
death
toll
hundr
interestingli
filovirus
recent
discov
one
nonretroviru
rna
paleovirus
identifi
mammalian
genom
suggest
ancient
relationship
mammal
grow
evid
suggest
bat
natur
reservoir
ebov
wild
today
current
treatment
ebola
hemorrhag
fever
pure
support
lack
effect
intervent
underscor
import
develop
broadlyprotect
vaccin
confer
longlast
immun
abil
develop
vaccin
critic
depend
understand
mechan
ebov
suppress
distract
otherwis
evad
host
immun
respons
one
wide
hypothes
immun
evas
mechan
employ
ebola
viru
secret
truncat
viral
glycoprotein
ebov
infect
cell
ebov
surfac
glycoprotein
gp
mediat
host
cell
attach
fusion
primari
structur
compon
expos
viru
surfac
reason
gp
focu
ebov
vaccin
research
gener
accept
robust
antigp
antibodi
respons
crucial
protect
lethal
ebov
challeng
ebov
gp
form
trimer
spike
virion
surfac
similarli
influenza
ha
hiv
env
also
like
ha
env
gp
first
synthes
uncleav
precursor
gp
cleav
golgi
complex
proteas
furin
two
function
subunit
ntermin
gp
subunit
contain
put
receptorbind
domain
rbd
ctermin
gp
subunit
contain
fusion
apparatu
transmembran
domain
gp
encod
two
disjoint
read
frame
viru
genom
two
read
frame
join
togeth
slippag
viral
polymeras
edit
site
tract
insert
th
gener
mrna
transcript
allow
readthrough
translat
gp
howev
transcript
edit
remain
unedit
transcript
prematur
stop
codon
result
synthesi
truncat
glycoprotein
product
sgp
secret
larg
quantiti
extracellular
space
though
product
conserv
ebov
speci
consider
debat
regard
function
sgp
unlik
gp
sgp
form
homodim
appear
intrins
antiinflammatori
activ
recent
find
ebov
quickli
mutat
synthes
primarili
gp
cell
cultur
mutant
viru
revert
primarili
sgpproduc
phenotyp
vivo
suggest
import
role
sgp
viru
surviv
within
host
sgp
share
sequenc
ntermin
region
gp
initi
hypothes
sgp
function
decoy
antigp
antibodi
earli
effort
identifi
activ
yield
mix
result
observ
antibodi
often
crossreact
sgp
gp
cast
doubt
hypothesi
furthermor
recent
studi
demonstr
immun
gp
elicit
antibodi
larg
epitop
share
sgp
howev
studi
investig
monoclon
antibodi
anim
immun
vaccin
contain
express
primarili
gp
repres
state
natur
infect
note
one
earli
studi
examin
monoclon
antibodi
mice
immun
venezuelan
equin
enceph
replicon
produc
gp
sgp
found
mani
antibodi
crossreact
gp
sgp
monoclon
antibodi
isol
human
ehf
survivor
shown
preferenti
react
sgp
studi
suggest
sgp
may
play
import
role
alter
host
antibodi
respons
studi
demonstr
sgp
induc
host
antibodi
respons
focus
epitop
share
gp
therebi
allow
bind
compet
antigp
antibodi
describ
mechan
term
antigen
subvers
distinct
previous
propos
decoy
mechan
secret
glycoprotein
simpli
passiv
absorb
antiglycoprotein
antibodi
importantli
demonstr
sgp
also
subvert
exist
antigp
immun
respons
weakli
crossreact
sgp
antigen
subvers
repres
novel
host
immun
evas
mechan
import
implic
ebov
vaccin
design
may
shed
light
viru
surviv
natur
reservoir
first
gener
ebov
gp
construct
individu
express
gp
sgp
natur
infect
ebov
direct
synthesi
sgp
gp
differenti
edit
mrna
transcript
fig
howev
observ
dnadepend
rna
polymeras
ddrp
edit
effici
ebov
rna
polymeras
furthermor
addit
polymeras
slippag
possibl
edit
site
also
serv
prematur
polyadenyl
signal
well
ribosom
slippag
signal
thu
gener
panel
ebov
gp
edit
site
mutant
order
control
level
sgp
gp
express
fig
made
insert
th
wild
type
edit
site
result
gp
domin
gene
product
silent
arg
mutat
introduc
edit
site
ablat
transcript
slippag
result
gp
edit
express
gp
sole
gene
product
mutat
also
introduc
gener
sgpedit
express
sgp
sole
gene
product
construct
subclon
mammalian
express
vector
pcagg
protein
express
examin
hela
cell
fig
cell
data
shown
cell
transfect
gp
edit
express
gp
intracellularli
surfac
secret
gp
supernat
previous
character
tacedepend
cleavag
interestingli
gp
edit
produc
higher
amount
gp
sgpedit
express
high
level
sgp
secret
effici
supernat
gp
express
undetect
like
minim
ddrpmediat
edit
express
experi
demonstr
mutat
edit
site
signific
effect
gp
express
next
investig
immunogen
edit
site
mutant
dna
vaccin
femal
balbc
mice
immun
gp
sgpproduc
construct
fig
mice
immun
sgpedit
construct
develop
similar
titer
antigp
antibodi
measur
elisa
mice
immun
gp
edit
develop
fourfold
higher
titer
antigp
antibodi
fig
mice
immun
construct
express
predominantli
sgp
sgpedit
develop
much
higher
titer
antisgp
antibodi
mice
immun
construct
express
predominantli
gp
gp
edit
fig
shown
fig
gp
immun
mice
develop
much
higher
titer
gp
bind
antibodi
sgpbind
antibodi
hand
sgpimmun
mice
develop
much
higher
titer
sgpbind
antibodi
gp
bind
antibodi
despit
fact
sgp
share
roughli
linear
sequenc
gp
result
suggest
sgpimmun
anim
either
mani
sgpbind
antibodi
direct
conform
epitop
share
gp
direct
share
epitop
inaccess
gp
sgp
compet
bind
antigp
antibodi
induc
sgp
gp
given
anim
immun
gp
sgp
develop
antibodi
preferenti
bind
differ
gp
isoform
perform
western
blot
analysi
determin
differ
linear
epitop
target
antibodi
gp
versu
sgpimmun
mice
shown
fig
antisera
gp
immun
mice
react
strongli
gp
weakli
sgp
hand
antisera
sgpimmun
mice
react
strongli
sgp
weakli
gp
suggest
linear
epitop
target
antigp
antibodi
gp
immun
mice
unshar
sgp
investig
whether
gp
bind
sgpbind
antibodi
immun
mice
crossreact
two
gp
isoform
separ
popul
antibodi
perform
competit
elisa
determin
sgp
could
compet
gp
gp
bind
antibodi
fig
similar
western
blot
data
sgp
unabl
function
ebola
viru
ebov
secret
glycoprotein
sgp
long
debat
fact
sgp
product
conserv
among
known
ebov
speci
strongli
indic
import
role
viral
life
cycl
furthermor
recent
find
ebov
mutat
predominantli
nonsgpform
phenotyp
cell
cultur
mutant
viru
revert
sgpform
phenotyp
vivo
suggest
sgp
critic
ebov
surviv
infect
host
demonstr
sgp
function
absorb
antigp
antibodi
importantli
instead
simpli
passiv
absorb
host
antibodi
sgp
activ
subvert
host
immun
respons
induc
crossreact
epitop
share
membranebound
gp
immun
subvers
sgp
repres
distinct
mechan
use
secret
antigen
antibodi
decoy
immun
evas
tactic
previous
propos
virus
import
consider
futur
ebov
vaccin
design
effort
sinc
vaccin
may
need
specif
tailor
avoid
subvers
compet
bind
antigp
antibodi
gp
immun
mice
fig
hand
sgp
abl
effici
compet
antigp
antibodi
sgpimmun
mice
expect
gp
abl
compet
group
fig
furthermor
observ
ident
reactiv
pattern
nativ
membraneanchor
ebov
gp
use
cell
surfac
competit
elisa
supplement
fig
examin
abil
two
gp
isoform
compet
antibodi
perform
competit
immunoprecipit
purifi
gp
presenc
sgp
vari
molar
ratio
immunoprecipit
antiserum
gp
immun
sgpimmun
mice
analyz
western
blot
use
polyclon
rabbit
antibodi
react
gp
isoform
antiserum
gp
immun
mice
precipit
gp
sgp
increas
concentr
sgp
attenu
amount
gp
signal
fig
suggest
presenc
two
separ
popul
antibodi
crossreact
gp
sgp
howev
antiserum
sgpimmun
mice
also
precipit
gp
sgp
increas
concentr
sgp
significantli
attenu
amount
gp
precipit
fig
indic
gp
reactiv
antibodi
mice
crossreact
sgp
control
addit
recombin
ha
effect
amount
gp
precipit
either
antiserum
group
taken
togeth
data
suggest
antigp
antibodi
induc
gp
direct
primarili
epitop
share
gp
sgp
wherea
antibodi
induc
sgp
direct
epitop
share
gp
sgp
sgp
differenti
interfer
antibodymedi
viral
neutral
antisera
sgp
gp
immun
mice
investig
whether
differ
abil
antisera
immun
group
neutral
ebov
gp
mediat
viru
infect
whether
sgp
could
interfer
antibodymedi
neutral
pseudovirus
gener
use
envdefici
hiv
backbon
pseudotyp
zair
ebov
gp
order
achiev
consist
neutral
pool
sera
four
highest
respond
among
gp
immun
anim
among
sgpimmun
anim
antisera
group
abl
effect
neutral
pseudovirus
measur
luciferas
report
assay
fig
although
antisera
gp
immun
mice
exhibit
potent
neutral
activ
antisera
sgpimmun
mice
probabl
due
higher
overal
antigp
titer
determin
sgp
interfer
neutral
use
antiserum
dilut
correspond
neutral
activ
group
preincub
antisera
differ
amount
sgp
consist
competit
elisa
result
sgp
abl
complet
attenu
neutral
activ
antisera
sgpimmun
mice
effect
neutral
activ
antisera
gp
immun
mice
fig
purifi
influenza
ha
use
control
effect
neutral
activ
either
antiserum
group
similar
result
observ
use
antiserum
dilut
correspond
neutral
activ
supplement
fig
data
confirm
sgp
compet
gp
antigp
antibodi
interfer
antibodymedi
neutral
anim
expos
sgp
inabl
sgp
compet
gp
antibodi
gp
immun
mice
intrigu
consid
gp
share
almost
half
ectodomain
sequenc
sgp
reason
antibodi
may
direct
sole
gp
epitop
share
sgp
antibodi
may
direct
share
epitop
preferenti
bind
gp
conform
differ
two
gp
isoform
result
tertiari
quarternari
structur
steric
shield
address
possibl
use
quantiti
elisa
determin
rel
titer
estim
averag
affin
antibodi
gp
sgpimmun
anim
gp
sgp
individu
examin
purifi
polyclon
igg
five
highest
respond
gp
immun
sgpimmun
group
calcul
appar
dissoci
constant
k
antigp
antisgp
antibodi
appar
k
calcul
scatchard
analysi
describ
elsewher
repres
estim
averag
affin
antigp
antibodi
lower
appar
k
correpond
higher
averag
affin
consist
elisa
data
fig
mice
immun
gp
higher
titer
antigp
antibodi
antisgp
antibodi
fig
howev
measur
differ
appar
k
gp
bind
vs
sgpbind
antibodi
fig
indic
preferenti
bind
antibodi
anim
gp
due
affin
differ
differ
gp
isoform
mice
immun
sgp
observ
high
titer
antisgp
antibodi
low
level
antigp
antibodi
howev
antibodi
bind
gp
appear
modestli
lower
k
higher
averag
affin
sgpbind
antibodi
fig
futur
studi
monoclon
antibodi
direct
epitop
share
sgp
gp
provid
inform
whether
specif
antibodi
bind
two
gp
isoform
differ
affin
nonetheless
present
data
provid
evid
differ
affin
respons
antibodi
gp
sgpimmun
mice
react
preferenti
differ
gp
isoform
express
gp
context
sgp
allow
sgp
compet
antigp
antibodi
secret
surfac
glycoprotein
mechan
absorb
antivir
antibodi
hypothes
sever
virus
includ
vesicular
stomat
viru
solubl
g
respiratori
syncyti
viru
secret
g
immun
studi
design
femal
balbc
mice
immun
four
edit
site
mutant
construct
pcagg
vector
mice
vaccin
im
mg
dna
mgleg
accord
schedul
shown
b
antibodi
respons
gp
c
antibodi
respons
sgp
level
antibodi
respons
induc
ebov
gp
dna
construct
mice
measur
elisa
use
hisgp
hissgp
coat
antigen
antibodi
concentr
determin
standard
curv
express
mgml
antigp
igg
asterisk
indic
statist
signific
differ
group
pvalu
given
red
comparison
antibodi
level
gp
sgp
induc
ebov
gp
dna
construct
averag
titer
antigp
blue
antisgp
red
antibodi
within
immun
group
shown
comparison
gp
isoform
reactiv
profil
within
immun
group
asterisk
indic
statist
signific
differ
antigp
antisgp
titer
within
group
measur
pair
twotail
student
ttest
sgpmediat
immun
subvers
ebola
viru
plo
pathogen
wwwplospathogensorg
demonstr
rsv
secret
g
absorb
antig
antibodi
interfer
neutral
antibodydepend
cellmedi
viru
clearanc
howev
observ
ebov
sgp
compet
antigp
antibodi
mice
immun
sgp
led
us
hypothes
sgp
may
serv
role
alter
repertoir
epitop
host
immun
respons
direct
order
divert
host
immun
respons
toward
epitop
share
sgp
gp
test
hypothesi
vaccin
mice
ratio
sgpedit
gp
edit
fig
simul
antigen
express
ebov
infect
control
group
immun
either
sgpedit
gp
edit
plu
empti
pcagg
vector
keep
total
amount
dna
constant
proxi
vivo
antigen
express
hela
cell
transfect
correspond
ratio
sgpedit
gp
edit
pcagg
measur
western
blot
analysi
level
sgp
gp
express
lysat
cultur
supernat
cell
cotransfect
sgpedit
gp
edit
similar
cell
transfect
sgpedit
gp
edit
alon
fig
immun
group
gener
similar
titer
antigp
antibodi
fig
howev
antiserum
mice
immun
gp
sgp
display
differ
reactiv
pattern
detect
western
blot
antibodi
gp
sgp
immun
mice
ng
purifi
hissgp
hisgp
run
sdspage
denatur
condit
probe
pool
gp
edit
sgpedit
antisera
follow
blot
hrpconjug
goat
antimous
igg
b
schemat
competit
elisa
well
coat
gp
incub
pool
antisera
well
increas
concentr
compet
antigen
sgp
gp
compet
antibodi
two
hour
plate
wash
incub
hrpconjug
secondari
antibodi
follow
addit
substrat
develop
color
c
competit
elisa
antisera
mice
immun
sgpedit
gp
edit
dilut
give
similar
antigp
signal
dilut
antiserum
mix
increas
quantiti
purifi
hissgp
c
hisgp
incub
hisgp
coat
well
develop
describ
experi
perform
duplic
repeat
least
three
time
repres
result
shown
e
f
competit
immunoprecipit
pool
antisera
gp
editimmun
mice
e
sgpimmun
mice
f
incub
gp
purifi
sgp
gp
alon
fix
gp
increas
concentr
sgp
compet
antigp
antibodi
gp
incub
recombin
ha
neg
control
upper
panel
sgpedit
antisera
show
gp
portion
blot
longer
exposur
time
show
attenu
signal
increas
sgp
concentr
result
repres
three
independ
experi
sgpmediat
immun
subvers
ebola
viru
plo
pathogen
wwwplospathogensorg
perform
competit
elisa
use
antisera
sgpedit
gp
editimmun
mice
sgp
abl
compet
gp
antigp
antibodi
fig
mice
immun
gp
editvector
sgpeditvector
display
serum
reactiv
pattern
observ
previous
mice
immun
one
gp
isoform
boost
mice
second
time
almost
gp
antibodi
week
antisera
sgpedit
gp
editimmun
mice
absorb
sgp
interestingli
mice
immun
lower
ratio
sgpedit
gp
edit
signific
sgp
crossreact
also
observ
almost
antigp
antibodi
suscept
competit
mice
immun
ratio
sgp
gp
suscept
competit
mice
immun
ratio
sgp
gp
figur
similar
result
also
obtain
competit
immunoprecipit
assay
shown
fig
antiserum
sgpeditgp
editimmun
mice
abl
precipit
gp
sgp
increas
concentr
sgp
attenu
amount
gp
precipit
furthermor
sgpeditgp
edit
antiserum
abl
effect
neutral
pseudoviru
infect
fig
addit
exogen
sgp
almost
complet
inhibit
pseudoviru
neutral
fig
indic
sgp
effect
interfer
antibodi
mediat
neutral
mice
similar
observ
also
made
antiserum
concentr
correspond
neutral
fig
taken
togeth
data
confirm
sgp
direct
host
antibodi
respons
focu
epitop
share
gp
sgp
therebi
allow
sgp
compet
antibodi
interfer
antibodymedi
viru
neutral
furthermor
observ
sgp
compet
greater
proport
gp
antibodi
week
antisera
compar
week
suggest
iter
exposur
sgp
gradual
drive
host
dominantli
sgpreactiv
respons
sgp
subvert
gp
specif
antibodi
respons
order
test
hypothesi
express
sgp
modul
gp
specif
antibodi
respons
prime
boost
mice
either
sgpedit
gp
edit
boost
week
opposit
gp
isoform
fig
control
neutral
activ
antisera
determin
incub
pfu
gp
viru
dilut
pool
gp
immun
blue
sgpimmun
red
empti
pcagg
vectorimmun
black
antisera
neutral
measur
decreas
luciferas
express
compar
virusonli
control
h
b
interfer
ebov
gp
pseudoviru
neutral
sgp
abil
sgp
interfer
antibodydepend
neutral
determin
allow
sgp
compet
gp
pseudotyp
virus
antigp
antibodi
pool
gp
immun
blue
sgpimmun
red
antisera
fix
dilut
correspond
neutral
antisera
coincub
increas
dilut
histag
sgp
solid
marker
histag
influenza
ha
open
marker
rescu
infect
measur
describ
method
group
boost
gp
isoform
shown
fig
antigp
antibodi
induc
group
week
howev
mice
immun
gp
edit
boost
sgpedit
sgp
abl
effici
compet
antigp
antibodi
competit
elisa
fig
furthermor
sgp
also
abl
effici
compet
antigp
antibodi
mice
prime
sgpedit
boost
gp
edit
next
investig
whether
sgp
abl
interfer
viru
neutral
femal
balbc
mice
immun
im
mg
total
dna
per
immun
accord
schedul
shown
mice
immun
ratio
sgp
edit
gp
edit
pcagg
control
group
immun
sgp
edit
gp
edit
alon
plu
empti
pcagg
vector
keep
total
amount
immun
dna
constant
b
comparison
antibodi
respons
gp
mous
sera
collect
week
analyz
antigp
antibodi
elisa
use
gp
coat
antigen
c
sgp
competit
elisa
abil
sgp
compet
antigp
antibodi
determin
competit
elisa
figur
pool
antisera
analyz
mice
immun
gp
edit
blue
sgp
edit
red
ratio
sgp
edit
gp
edit
purpl
dilut
give
roughli
equival
antigp
signal
competit
elisa
perform
antisera
collect
week
light
color
week
dark
color
accord
immun
schedul
competit
immunoprecipit
pool
antisera
sgpeditgp
editimmun
mice
incub
gp
purifi
sgp
gp
alon
fix
gp
increas
concentr
sgp
compet
antigp
antibodi
gp
incub
recombin
ha
neg
control
precipit
analyz
figur
f
e
neutral
ebov
gp
pseudoviru
neutral
activ
antisera
determin
incub
pfu
gp
viru
dilut
pool
sgpgp
immun
red
empti
pcagg
vectorimmun
black
antisera
neutral
measur
decreas
luciferas
express
compar
virusonli
control
f
interfer
ebov
gp
pseudoviru
neutral
sgp
abil
sgp
interfer
antibodydepend
neutral
determin
figur
pool
sgpgp
immun
antisera
fix
dilut
correspond
neutral
antisera
coincub
increas
dilut
purifi
sgp
red
purifi
influenza
ha
blue
rescu
infect
measur
describ
method
sgpmediat
immun
subvers
ebola
viru
sera
cross
prime
boost
mice
shown
fig
sgp
abl
interfer
neutral
anim
prime
sgp
boost
gp
hand
antisera
anim
prime
gp
boost
sgp
maintain
neutral
activ
presenc
sgp
probe
observ
compar
antisera
titer
correspond
neutral
activ
nt
group
week
week
boost
opposit
gp
figur
abil
sgp
divert
antibodi
respons
gp
immun
studi
design
femal
balbc
mice
immun
im
mg
total
dna
per
immun
accord
schedul
two
group
mice
n
prime
boost
previou
experi
either
sgp
edit
gp
edit
pcagg
vector
group
divid
two
subgroup
boost
week
either
construct
initi
immun
opposit
edit
site
mutant
construct
b
comparison
antibodi
respons
gp
sera
collect
week
analyz
antibodi
gp
elisa
use
gp
coat
antigen
c
sgp
competit
elisa
abil
sgp
compet
antigp
antibodi
determin
competit
elisa
describ
figur
pool
antisera
analyz
mice
immun
sgp
edit
boost
week
either
gp
edit
red
sgp
edit
purpl
mice
immun
gp
edit
boost
week
either
gp
edit
blue
sgp
edit
green
elisa
experi
perform
duplic
least
three
time
repres
result
shown
interfer
ebov
gp
pseudoviru
neutral
sgp
abil
sgp
interfer
antibodydepend
neutral
determin
figur
pool
sgpprime
gp
boost
red
gp
prime
sgpboost
green
antisera
fix
dilut
correspond
neutral
antisera
coincub
increas
dilut
histag
sgp
solid
marker
histag
influenza
ha
open
marker
rescu
infect
measur
describ
method
e
comparison
neutral
titer
antiserum
titer
correspond
pseudoviru
neutral
activ
nt
calcul
week
fine
checker
week
coars
checker
mice
error
bar
correspond
confid
interv
determin
student
ttest
sgpmediat
immun
subvers
ebola
viru
plo
pathogen
wwwplospathogensorg
isoform
shown
fig
neutral
activ
boost
immun
opposit
gp
isoform
thu
appear
sgp
overwhelm
gp
specif
respons
also
boost
nonneutr
antibodi
induc
gp
observ
sgp
alter
reactiv
profil
antigp
respons
import
implic
ebov
vaccinolog
sinc
infect
sgp
could
subvert
figur
propos
mechan
antigen
subvers
region
gp
share
sgp
red
unshar
epitop
green
bcell
color
accord
region
gp
sgp
react
anim
begin
bcell
potenti
recogn
epitop
distribut
throughout
gp
sgp
sgp
express
much
higher
level
gp
occur
infect
bcell
recogn
sgp
epitop
mani
share
gp
red
region
sgp
gp
preferenti
activ
expand
compar
bcell
recogn
unshar
epitop
gp
green
region
gp
thu
sgpreactiv
antibodi
domin
immun
respons
b
prior
immun
sgp
sgp
share
linear
sequenc
gp
anim
prime
sgp
gener
antisgp
antibodi
mani
direct
epitop
share
gp
anim
individu
previous
infect
recov
ebov
infect
boost
gp
sgp
crossreact
memori
cell
outnumb
express
higher
affin
receptor
gp
specif
bcell
result
preferenti
expans
sgpcrossreact
bcell
predominantli
sgpreactiv
immun
respons
c
prior
immun
gp
prime
anim
gp
result
antibodi
larg
gp
epitop
share
sgp
presum
due
immunodomin
high
access
gp
mucin
domain
shield
share
epitop
anim
boost
sgp
infect
ebov
suffici
high
titer
antigp
antibodi
clear
infect
rapidli
memori
bcell
recogn
share
epitop
encount
cognat
antigen
expand
noncrossreact
gp
specif
bcell
boost
result
subvers
host
immun
respons
toward
sgp
crossreact
success
clearanc
ebov
infect
order
avoid
sgpmediat
antigen
subvers
high
enough
titer
noncrossreact
antigp
antibodi
must
maintain
rapidli
clear
ebov
infect
subvers
occur
sgpmediat
immun
subvers
ebola
viru
plo
pathogen
wwwplospathogensorg
immun
respons
previous
vaccin
individu
viru
clear
rapidli
role
sgp
ebov
host
immun
evas
clearli
defin
studi
analyz
antibodi
respons
mice
immun
sgp
gp
gp
isoform
present
evid
sgp
serv
redirect
immun
respons
toward
epitop
either
present
inaccess
gp
epitop
share
two
gp
isoform
therebi
allow
sgp
effect
absorb
antigp
antibodi
term
phenomenon
antigen
subvers
distinct
previous
propos
mechan
sgp
passiv
absorb
antiglycoprotein
antibodi
antigen
subvers
abil
sgp
absorb
antigp
antibodi
critic
depend
exposur
sgp
induct
antigp
immun
respons
mice
immun
gp
presenc
sgp
immun
strategi
design
simul
antigen
exposur
natur
infect
observ
result
antigp
antibodi
cross
reactiv
thu
suscept
competit
sgp
even
though
titer
antigp
antibodi
mice
similar
titer
mice
immun
gp
alon
hand
mice
immun
gp
alon
observ
low
crossreact
antigp
antibodi
sgp
find
consist
previou
studi
indic
antibodi
mice
larg
direct
epitop
share
sgp
model
propos
mechan
antigen
subvers
sgp
assum
immun
host
begin
repertoir
bcell
recogn
epitop
distribut
throughout
gp
sgp
fig
howev
sgp
gener
much
higher
quantiti
gp
bcell
recogn
sgp
epitop
epitop
share
sgp
gp
like
encount
cognat
antigen
compar
bcell
recogn
gp
specif
epitop
furthermor
sgpreactiv
bcell
popul
expand
outcompet
bcell
antigen
surviv
signal
thu
humor
respons
skew
toward
sgp
epitop
gp
share
sgp
antigen
subvers
repres
novel
viral
escap
strategi
similar
origin
antigen
sin
oa
classic
oa
initi
exposur
pathogen
result
popul
memori
bcell
recogn
antigen
specif
pathogen
strain
upon
subsequ
exposur
differ
strain
pathogen
crossreact
memori
bcell
respond
preferenti
produc
antibodi
high
affin
initi
pathogen
may
bind
new
strain
effect
furthermor
memori
bcell
compet
antigen
surviv
signal
bcell
might
otherwis
produc
higher
affin
protect
antibodi
new
strain
similarli
overexpress
ebola
viru
sgp
ensur
sgpreactiv
bcell
preferenti
expand
outcompet
gp
specif
bcell
antigen
surviv
signal
result
suboptim
host
respons
direct
away
membranebound
gp
virion
surfac
howev
unlik
classic
oa
process
requir
tempor
separ
antigen
encount
also
occur
simultan
exposur
two
partli
ident
antigen
model
antigen
subvers
also
explain
antigp
antibodi
anim
prime
sgp
boost
gp
maintain
crossreact
sgp
anim
prime
sgp
elicit
antibodi
sgp
epitop
share
gp
fig
anim
boost
gp
memori
bcell
recogn
share
epitop
vastli
outnumb
express
higher
affin
receptor
bcell
recogn
unshar
epitop
thu
antisgp
memori
bcell
preferenti
activ
expand
boost
antisgp
respons
situat
analog
one
previouslyinfect
individu
vaccin
gp
rais
possibl
immun
individu
may
simpli
boost
alreadi
unprotect
antibodi
respons
filoviru
infect
rare
find
suggest
may
necessari
devis
altern
strategi
immun
previouslyinfect
individu
way
specif
boost
antigp
respons
avoid
subvers
perhap
strike
find
studi
boost
gp
immun
mice
sgp
could
effect
subvert
antigp
respons
render
suscept
competit
sgp
hypothes
major
bcell
activ
mice
immun
gp
direct
epitop
share
sgp
fig
small
popul
activ
bcell
react
sgp
support
observ
even
though
sgp
measur
compet
elisa
immunoprecipit
antigp
antibodi
gp
immun
mice
mice
still
develop
low
titer
sgpbind
antibodi
gp
immun
mice
boost
sgp
sgpreactiv
bcell
expand
remain
gp
bcell
recogn
unshar
epitop
shift
antigp
antibodi
respons
mostli
gp
specif
mostli
sgpcross
reactiv
furthermor
notabl
neutral
activ
actual
decreas
boost
sgp
despit
increas
overal
antigp
antibodi
thu
boost
sgp
augment
nonneut
antigp
antibodi
highli
suscept
sgp
competit
exist
neutral
antibodi
previous
induc
gp
mice
maintain
resist
sgp
interfer
situat
analog
one
individu
immun
gp
subsequ
infect
ebov
individu
unabl
rapidli
clear
viru
viru
may
replic
suffici
subvert
host
immun
respons
thu
critic
vaccin
induc
high
enough
titer
antigp
antibodi
ensur
viru
clear
abl
effect
subvers
fig
inabl
sgp
compet
antigp
antibodi
gp
immun
mice
consist
grow
bodi
evid
point
immunodomin
gp
mucin
domain
highli
glycosyl
region
gp
share
sgp
domain
thought
form
steric
bulki
cloak
shield
put
receptor
bind
domain
host
antibodi
suggest
hiv
env
glycan
shield
role
mucin
domain
play
hostpathogen
interact
complex
previou
studi
indic
region
contain
neutral
infectionenhanc
epitop
mask
epitop
gp
steric
occlus
furthermor
mucin
domain
diverg
region
gp
among
ebov
strain
dispens
gp
mediat
viru
attach
membran
fusion
strongli
suggest
role
protect
function
conserv
region
gp
immun
attack
linear
sequenc
sgp
correspond
put
mucinshield
receptor
bind
domain
rbd
gp
possibl
sgp
work
togeth
mucin
domain
host
antibodi
direct
either
share
epitop
steric
shield
gp
trimer
mucin
domain
cleav
host
cell
acidifi
endosom
along
bound
antibodi
possibl
gp
epitop
share
sgp
may
shield
gp
trimer
support
observ
antisgp
antibodi
sgpimmun
mice
crossreact
gp
despit
fact
sgp
share
linear
sequenc
gp
furthermor
antigen
subvers
allow
sgp
effici
absorb
antibodi
recogn
unshield
share
epitop
gp
import
sgpmediat
antigen
subvers
ehf
pathogenesi
remain
elucid
passiv
immun
studi
polyclon
sera
monoclon
antibodi
reveal
whether
sgpcrossreact
antibodi
fact
less
protect
gp
specif
antibodi
particularli
import
given
passiv
transfer
antiebov
monoclon
antibodi
gain
traction
recent
postexposur
therapeut
sgp
crossreact
turn
correl
impair
viru
clearanc
would
underscor
need
elicit
produc
gp
specif
antisera
monoclon
antibodi
achiev
effect
treatment
ebov
infect
moreov
find
also
suggest
ebov
vaccin
tailor
target
region
share
sgp
gp
particularli
relev
recent
effort
develop
broadlyprotect
vaccin
sinc
studi
center
around
focus
vaccin
conserv
epitop
delet
highli
variabl
region
gp
mucin
domain
sgp
actual
correspond
highli
conserv
region
gp
antibodi
elicit
construct
may
crossreact
sgp
therefor
suscept
sgpmediat
subvers
candid
panfiloviru
vaccin
may
need
focus
region
gp
highli
conserv
unshar
sgp
membraneproxim
gp
subunit
also
great
interest
ebov
vaccinolog
determin
whether
antigen
subvers
correl
success
failur
vaccin
protect
anim
lethal
challeng
may
critic
ebov
vaccin
elicit
long
last
immun
respons
high
enough
antibodi
titer
host
clear
viru
abl
replic
effect
antigen
subvers
possibl
consist
nonhuman
primat
lethal
challeng
experi
surviv
close
correl
mainten
antigp
antibodi
titer
threshold
level
lower
antibodi
titer
delay
time
death
much
ebov
vaccinolog
focus
elicit
protect
antibodi
membranebound
glycoprotein
robust
tcell
respons
may
also
improv
vaccin
efficaci
immun
nonhuman
primat
low
dose
gp
nucleoprotein
np
express
recombin
adenovirus
demonstr
elicit
robust
antibodi
tcell
respons
confer
protect
lethal
challeng
importantli
ebovspecif
tcell
shown
reduc
threshold
antigp
antibodi
need
protect
recombin
vector
express
ctl
epitop
demonstr
confer
protect
lethal
ebov
challeng
mice
gpspecif
well
nucleoprotein
np
specif
tcell
control
infect
even
adopt
transfer
otherwis
anim
studi
suggest
robust
tcell
respons
may
reduc
threshold
antibodi
need
rapid
viru
clearanc
noteworthi
although
express
sgp
conserv
ebola
virus
sgp
produc
marburg
viru
marv
anoth
member
filovirida
instanc
relat
virus
often
diverg
mechan
employ
surviv
respect
host
exampl
sendai
viru
sev
paramyxoviru
caus
sever
respiratori
tract
infect
rodent
express
v
protein
via
rna
edit
p
gene
v
necessari
vivo
surviv
pathogenesi
sev
though
vdefici
sev
show
defect
replic
vitro
howev
close
relat
human
parainfluenza
viru
type
express
v
even
though
p
gene
display
high
degre
homolog
sev
p
caus
similar
diseas
human
sev
caus
rodent
similarli
secret
gp
observ
marv
like
evolv
altern
strategi
surviv
within
host
precis
relev
antigen
subvers
ebola
vaccinolog
remain
determin
antigen
subvers
repres
novel
eleg
solut
challeng
virus
face
balanc
abil
infect
host
cell
effici
evad
host
immun
surveil
constraint
small
genom
neccessit
pack
great
deal
function
small
space
sgpmediat
subvers
repres
mechan
along
glycandepend
steric
shield
immunodomin
gp
mucin
domain
may
help
ebov
surviv
host
improv
understand
mechan
work
togeth
eventu
open
door
ration
design
vaccin
vaccin
direct
highli
conserv
region
gp
gp
subunit
could
induc
broadli
reactiv
antibodi
also
avoid
potenti
sgpmediat
immun
subvers
vaccin
could
protect
multipl
strain
ebov
includ
strain
yet
identifi
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
ethic
approv
immun
studi
mice
obtain
institut
anim
care
use
committe
iacuc
emori
univers
anim
studi
perform
approv
institut
anim
care
use
committe
iacuc
emori
univers
femal
balbc
mice
old
purchas
jackson
laboratori
hous
anim
facil
emori
univers
cell
hela
cell
maintain
dulbecco
modifi
eagl
medium
dmem
mediatech
supplement
fetal
bovin
serum
hyclon
thermofish
penicillinstreptomycin
ebola
glycoprotein
construct
base
ebola
zair
strain
zebov
mayinga
subtyp
genbank
access
edit
site
mutant
gener
pbluescript
ii
ks
vector
sitedirect
mutagenesi
use
quickchang
xl
kit
stratagen
construct
subclon
pcagg
mammalian
express
vector
protein
express
carri
transfect
confluent
cell
plate
mg
ml
fugen
hd
roch
per
well
per
manufactur
instruct
detect
h
post
transfect
surfac
express
detect
surfac
biotinyl
follow
immunoprecipit
antiebov
gp
mous
polyclon
antibodi
sdspage
avidinhrp
blot
cell
lysat
harvest
cell
lysi
buffer
cell
cultur
supernat
collect
spun
remov
cell
debri
concentr
centrifug
concentr
cell
lysat
concentr
cell
cultur
supernat
run
sdspage
denatur
condit
follow
probe
antiebov
gp
sgp
rabbit
polyclon
antibodi
mutant
zebov
gp
plasmid
dna
immun
experi
prepar
use
endofre
plasmid
mega
kit
qiagen
per
manufactur
instruct
redissolv
pure
endotoxinfre
water
concentr
mgml
puriti
verifi
restrict
analysi
spectrophotometri
immun
dna
dilut
steril
pb
mgml
filter
steril
femal
balbc
mice
charl
river
laboratori
six
mice
per
group
receiv
mg
dna
intramuscularli
mgleg
per
immun
anesthet
mice
bled
retroorbit
two
week
immun
serum
sampl
store
use
product
purifi
histidinetag
ha
describ
previous
solubl
histidinetag
gp
sgp
gener
ctermin
addit
singl
histidin
tag
solubl
gp
gener
truncat
transmembran
domain
cytoplasm
tail
recombin
vaccinia
virus
rvv
gener
describ
elsewher
synthes
solubl
histag
gp
hisgp
sgp
hissgp
well
membranebound
gp
product
purif
hisgp
hissgp
rvvinfect
cell
supernat
clarifi
purifi
use
prepeas
purif
kit
affymetrix
puriti
recombin
protein
verifi
sdspage
follow
western
blot
coomassi
stain
purifi
hisgp
hissgp
test
reactiv
preimmun
sera
sera
unvaccin
mice
elisa
western
blot
found
unreact
elisa
flatbottom
immulon
plate
thermo
coat
overnight
mgwell
hisgp
hissgp
standard
curv
gener
coat
control
well
known
concentr
mous
igg
plate
wash
pbstween
pbst
block
bsa
incub
duplic
two
hour
antisera
dilut
bsa
plate
wash
incub
pool
antiigg
subtyp
hrpconjug
goat
antimous
secondari
antibodi
final
wash
plate
develop
tmb
thermo
stop
minut
hcl
plate
read
antibodi
concentr
calcul
use
standard
curv
competit
elisa
perform
modifi
protocol
plate
coat
hisgp
pool
antisera
dilut
bsa
concentr
correspond
od
antigp
elisa
dilut
antisera
mix
decreas
concentr
purifi
hissgp
hisgp
immedi
ad
hisgp
coat
well
elisa
develop
describ
competit
calcul
percent
signal
compar
compet
antigen
competit
immunoprecipit
perform
incub
pool
antisera
normal
antigp
titer
determin
elisa
ng
purifi
hisgp
increas
amount
purifi
hissgp
molar
ratio
sgp
gp
antisera
incub
hissgp
alon
hisgp
alon
gp
use
control
well
antisera
incub
gp
presenc
recombin
influenza
ha
sampl
incub
ice
minut
follow
addit
prote
coupl
agaros
bead
thermo
scientif
incub
addit
two
hr
agit
sampl
centrifug
wash
three
time
lysi
buffer
mix
laemmli
sd
sampl
buffer
bmercaptoethanol
sampl
heat
minut
use
sdspage
follow
western
blot
analysi
use
antibodi
gainst
sgp
gp
appar
affin
polyclon
antisera
determin
quantit
elisa
use
purifi
igg
immun
anim
igg
purifi
use
melon
gel
thermo
per
manufactur
instruct
puriti
igg
verifi
elisa
coomassi
gel
stain
sinc
quantit
affin
elisa
requir
coat
antigen
incub
increas
dilut
antibodi
coat
antigen
becom
satur
found
high
antibodi
concentr
result
signal
exceed
plate
reader
rang
detect
thu
titrat
amount
coat
antigen
mgwell
avoid
signal
satur
well
coat
overnight
mg
purifi
hisgp
hissgp
wash
block
incub
purifi
igg
dilut
bsa
dilut
rang
base
origin
serum
volum
elisa
develop
describ
signal
convert
nm
concentr
igg
comparison
standard
curv
appar
k
polyclon
sera
calcul
nonlinear
regress
analysi
use
graphpad
prism
result
verifi
manual
analysi
linear
bind
curv
detail
elsewher
ebovgp
pseudotyp
hiv
gener
describ
elsewher
briefli
cotransfect
envdefect
hiv
backbon
zebov
gp
pcagg
vector
use
fugen
hd
roch
supernat
harvest
h
posttransfect
clarifi
filter
use
micron
filter
pseudovirus
titer
infect
cell
express
bgalactosidas
luciferas
tatactiv
promot
caus
infect
cell
turn
blue
xgal
stain
neutral
assay
perform
describ
elsewher
minor
modif
briefli
pseudovirus
preincub
dilut
heatinactiv
antisera
supplement
heatinactiv
mous
sera
innov
research
total
volum
mous
serum
pseudovirusantiserum
mixtur
ad
confluent
cell
incub
h
viru
infect
neutral
measur
luciferas
report
assay
neutral
measur
decreas
luciferas
express
compar
virusonli
control
perform
competit
neutral
assay
select
fix
antisera
concentr
correspond
either
neutral
activ
dilut
antisera
incub
dilut
purifi
hissgp
solubl
influenza
hemagluttinin
ha
control
genbank
access
antisera
mixtur
mix
pseudoviru
neutral
assay
develop
describ
interfer
neutral
determin
percent
rescu
infect
compar
well
pseudovirusantisera
without
compet
sgp
calcul
formula
virusantibodi
sgp
virusantibodi
viru
alon
virusantibodi
figur
competit
cell
surfac
elisa
hela
cell
seed
plate
allow
grow
overnight
confluenc
cell
infect
moi
recombin
vaccinia
viru
direct
infect
cell
express
membranebound
ebov
gp
h
postinfect
cell
fix
paraformaldehyd
wash
pb
pool
antisera
mice
immun
sgpedit
light
red
dark
red
light
blue
gp
edit
dark
blue
dilut
give
roughli
equival
antigp
signal
dilut
antiserum
mix
increas
quantiti
purifi
hissgp
incub
fix
gp
express
cell
two
hour
allow
sgp
compet
gp
antibodi
elisa
develop
previous
describ
except
detergentfre
pb
use
wash
step
tif
figur
interfer
antibodymedi
neutral
sgp
neutral
activ
abil
sgp
interfer
antibodydepend
neutral
determin
ident
figur
except
concentr
antisera
fix
correspond
neutral
pool
gp
immun
blue
sgpimmun
red
antisera
coincub
increas
dilut
hissgp
solid
marker
hisinfluenza
ha
open
marker
rescu
infect
measur
describ
method
tif
figur
express
gp
sgp
togeth
antigen
express
dna
vaccin
low
detect
vivo
measur
express
cell
cultur
proxi
vivo
express
hela
cell
plate
transfect
gp
edit
sgpedit
empti
pcagg
vector
ratio
use
immun
anim
mg
total
dna
per
well
express
sgp
gp
determin
h
posttransfect
cell
lysat
cultur
supernat
western
blot
use
polyclon
rabbit
antibodi
react
gp
isoform
volum
cell
lysat
supernat
analyz
sampl
proport
total
amount
lysat
supernat
collect
western
blot
reflect
rel
amount
total
sgp
gp
produc
tif
figur
immun
lower
ratio
sgp
gp
femal
balbc
mice
immun
im
mg
total
dna
per
immun
previou
immun
experi
boost
week
amount
gp
edit
fix
mg
group
immun
ratio
sgp
edit
gp
edit
well
gp
edit
without
sgpedit
total
immun
dna
normal
mg
empti
pcagg
vector
top
panel
sgp
competit
elisa
pool
antisera
analyz
immun
mice
week
abil
sgp
compet
antigp
antibodi
determin
competit
elisa
describ
figur
bottom
panel
vitro
antigen
express
hela
cell
transfect
gp
edit
sgpedit
empti
pcagg
vector
ratio
use
immun
anim
mg
total
dna
per
well
express
sgp
gp
determin
h
posttransfect
describ
figur
cell
lysat
cultur
supernat
analyz
western
blot
use
polyclon
rabbit
antibodi
react
gp
isoform
tif
figur
interfer
antibodymedi
neutral
sgp
neutral
activ
gp
sgp
antisera
abil
sgp
interfer
antibodydepend
neutral
determin
ident
figur
except
antiserum
concentr
fix
correspond
neutral
pool
gp
sgpimmun
antisera
coincub
increas
dilut
sgp
red
influenza
ha
blue
rescu
infect
measur
describ
method
tif
